Tau PET Imaging With 18F-T807(AV1451) in Neurodegenerative Disorders

NCT04926259 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Neurodegenerative Disorders

Interventions

DRUG: 18F-T807

Sponsor

First Affiliated Hospital of Fujian Medical University